Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,182,272
-
Share change
-
+1,037,022
-
Total reported value
-
$676,263,723
-
Put/Call ratio
-
79%
-
Price per share
-
$25.83
-
Number of holders
-
125
-
Value change
-
+$27,554,401
-
Number of buys
-
73
-
Number of sells
-
44
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q2 2018
As of 30 Jun 2018,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,182,272 shares.
The largest 10 holders included
Point72 Asset Management, L.P., STATE STREET CORP, Invesco Ltd., BlackRock Inc., Broadfin Capital, LLC, MACQUARIE GROUP LTD, PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, and JANUS HENDERSON GROUP PLC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.